Wood; Jill

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wood; Jill.The latest application filed is for "substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis".

Company Profile

0.6.7

Wood; Jill - Fort Collins CO
Wood; Jill - Ft. Collins CO
WOOD; Jill - North Haven CT
WOOD; Jill - Hamden CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Grant RE46,856 - Hentemann , et al. May 22, 2	2018-05-22
Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis Grant 8,859,572 - Hentemann , et al. October 14, 2	2014-10-14
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline Derivatives Useful For Treating Hyper-proliferative Disorders And Diseases Associated With Angiogenesis App 20130261113 - HENTEMANN; Martin ; et al.	2013-10-03
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Grant 8,466,283 - Hentemann , et al. June 18, 2	2013-06-18
Inhibition Of P38 Kinase Activity Using Substituted Heterocyclic Ureas App 20120149706 - DUMAS; Jacques ; et al.	2012-06-14
Inhibition Of P38 Kinase Activity Using Substituted Heterocyclic Ureas App 20120046290 - Dumas; Jacques ; et al.	2012-02-23
Sulfone Substituted 2,3-dihydroimidazo [1,2-c] Quinazoline Derivatives Useful For Treating Hyper-proliferative Disorders And Diseases With Angiogenesis App 20110190281 - Hentemann; Martin ; et al.	2011-08-04
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis App 20110083984 - Hentemann; Martin ; et al.	2011-04-14
Hydroxy, .omega.-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors Grant 7,528,255 - Riedl , et al. May 5, 2	2009-05-05
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors App 20080153823 - Riedl; Bernd ; et al.	2008-06-26
Quinolone Carboxylic Acid Derivatives for Treatment of Hyperproliferative Conditions App 20070213339 - Khire; Uday ; et al.	2007-09-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.